Looking to publish in The Lancet Infectious Diseases? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowThe Lancet Infectious Diseases is a journal with ISSN 1473-3099 and a manuscript submission link through Editorial Manager. The homepage highlights current issues, online first content, series, commissions, audio, and journal metrics including an Impact Factor of 31 and a CiteScore of 42.6.
Looking to publish in The Lancet Infectious Diseases? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
The Lancet Infectious Diseases accepts the following article types. Click on an article type to view submission instructions.
Article
Seminar
Review
Systematic Review
Meta-Analysis
Primary Research Articles
Correspondence
Therapeutics Papers
Public Health
Clinical Picture
Recent Publications
Building the evidence base for long COVID treatments
Tiffany A Walker
The spread of sexually transmissible drug-resistant shigellosis in England: a genomic epidemiology study
Julia E Marshall, Noemie Lefrancq, Lewis C E Mason, Fariha Jawed, Yi Ling Tam, Claire Jenkins, Henrik Salje, Kate S Baker
Efficacy and safety of rivaroxaban, colchicine, and famotidine–loratadine with specialist supportive clinical care for fatigue in patients with post-COVID-19 condition in the UK: a multisite, open-label, randomised controlled trial
Emma C Wall, Gordon Prescott, Hakim M Dehbi, Janet Scott, Rachael A Evans, Kim Horstmanshof, Caroline L Watkins, Melissa J Heightman, Amitava Banerjee, Charlotte Adams-Heath, Gail Allsopp, Nisreen A Alwan, Emily Attree, Kumaran Balasundaram, Rajarshi Banerjee, Elena Bax, Fauzia Begum, Robert Bell, Valerio Benedetto, Amelia Blow, Rachel Botell, Jacob Bretherick, Christopher Brown, Sophie Burchell-Kirk, Matthew R Burns, Al-Tahoor Butt, Anu Chandra, Andrew Clegg, Sarah Clegg, Donna Clutterbuck, Stephen Cone, Michael Crooks, Phil Cumberlidge, Dan Cuthbertson, Ashkan Dashtban, Andrea Dennis, Samantha Eccles, Terence Elliott-Cooper, Sophie Equi, Lere Fisher, Eamonn Foley, Denise Forshaw, Emily Fraser, Mark Gabbay, Francesco Gambino, Alison Gibbon, Manuel Gomes, Henry Goodfellow, Angela Green, Helen Grice, Jasmine Hayer, Rachel Hext, Keri Hildick, Toby Hillman, Lyth Hishmeh, Claire Hooper, Tushy Kailayanathan, Kiran Khan, Kamlesh Khunti, Nataliia Kryvutenko, Charles Latchford, Maya Leach, Mag Leahy, Gregory Y H Lip, Rebecca Livingston, Paula Lorgelly, Antony Loveless, Rita Mallinson, Amir Manzelat, Pablo F Medina, Emma Mi, Mohamed Mohamed, Hugh Montgomery, Yi Mu, Elizabeth Murray, Florence Mutesva, Josie Newton, Rachel Nyam, Lauren O'Mahoney, Marija Pantelic, Annalisa Parabita, Laura Pasea, Joanna Peel, Jai Prashar, Mel Ramasawmy, Deepak Ravindran, Chris Robson, Jagdeep Sahota, Amanpreet Sarna, Ileana L Selejan, Ondine Sherwood, Natalie Smith, William David Strain, Ting L Su, David Sunkersing, Rob Suriano, Jennifer Sweetman, Svetlana Tishkovskaya, Christina M van der Feltz-Cornelis, Anand Viswanathan, Han I Wang, Jonathan Waywell, Andrew Williams, Rachel Williams, Nefyn Williams, Daniel Wootton, Joanna Wright, Michael Zandi
Cefiderocol heteroresistance in NDM Enterobacterales
Tugba Ozturk, Sarah Lohsen, Sarah W Satola, David S Weiss
Frequently asked questions
How long does it take to publish?
Fast-track submissions receive a decision on prioritisation within 48 h, the initial decision on publication is typically reached within 2 weeks, accepted fast-track papers normally publish online within 28 days of submission, and authors are informed at least a week in advance of Online First publication. Proofs should be corrected and returned within 48 h.
Reformat to The Lancet Infectious Diseases using Livewrite PremiumIs a cover letter required?
A covering letter should be uploaded at the Enter Comments stage of submission. It should explain why the paper should be published in the journal, and detailed responses to reviewers’ comments in a covering letter are necessary with revisions.
Reformat to The Lancet Infectious Diseases using Livewrite PremiumWhat are the publication costs?
Submission is free. The journal is hybrid and offers gold open access for eligible funded research articles and a green open access option; APC details are provided through the journal’s open access information.
Reformat to The Lancet Infectious Diseases using Livewrite Premium